Transcranial Magnetic Stimulation (TMS) Evaluation of Central Nervous System (CNS) Pharmacodynamic (PD) Activity of Brexanolone in Healthy Male Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-503019-40-00

Acronym

547-TRM-101

Enrollment

Registered

2023-04-28

Start date

2023-05-11

Completion date

2023-10-09

Last updated

2023-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NA, PD study in Healthy Volunteers

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026